Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Alcohol Use Disorder
NCT07325266Phase 2Recruiting
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in alcohol use disorder (AUD), sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Apr 2026; status: recruiting.
02
Drugs
apremilast
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07325266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07325266.